NAPRO BIOTHERAPEUTICS INC·4

Sep 4, 6:29 PM ET

WHITE JEFFREY 4

4 · NAPRO BIOTHERAPEUTICS INC · Filed Sep 4, 2003

Insider Transaction Report

Form 4
Period: 2003-09-02
WHITE JEFFREY
President, Genomics
Transactions
  • Award

    Stock Options (right to buy)

    2003-09-02$1.55/sh+60,000$93,00060,000 total
    Exercise: $1.55Exp: 2013-09-02Common Stock (60,000 underlying)
Footnotes (1)
  • [F1]Such options fully vest and become exercisable on September 2, 2008. Such options may vest earlier if the issuer's stock price, on a rolling 20 day average, exceeds $1.55 (the issuer's stock price on September 2, 2003, the grant date). If the issuer's 20-day rolling average stock price exceeds $1.55 by 30%, then 16.67% of the options vest. Likewise, if the 20-day rolling average stock price exceeds $1.55 by 60%, 90%, 120%, 150% and 200%, then in each case an additional 16.67% of the options vest.

Documents

2 files
  • 4
    edgar.xmlPrimary

    FORM 4 -

  • EX-24

    POWER OF ATTORNEY